Safety of herpes zoster vaccine in the Shingles prevention study: A randomized trial

Annals of Internal Medicine

Volumn 152, Issue 9, 2010, Pages 545-554

  Simberkoff, Michael S ^a   Arbeit, Robert D ^b   Johnson, Gary R ^c   Oxman, Michael N ^d   Boardman, Kathy D ^e   Williams, Heather M ^f   Levin, Myron J ^g   Schmader, Kenneth E ^h   Gelb, Lawrence D ⁱ   Keay, Susan ^j   Neuzil, Kathleen ^k   Greenberg, Richard N ^l   Griffin, Marie R ^m   Davis, Larry E ^e   Morrison, Vicki A ^a   Annunziato, Paula W ⁿ  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b TUFTS MEDICAL CENTER   (United States)

^c VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^d VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^e VA Medical Center   (United States)

^f NATIONAL CANCER INSTITUTE   (United States)

^g UNIVERSITY OF COLORADO   (United States)

^h DURHAM VA MEDICAL CENTER   (United States)

ⁱ PATH ^*  (United States)

^j BALTIMORE VA MEDICAL CENTER   (United States)

^k PATH   (United States)

^l UNIVERSITY OF KENTUCKY   (United States)

^m VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

ⁿ MERCK RESEARCH LABORATORIES   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; VARICELLA ZOSTER VACCINE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG SAFETY; DRUG TOLERABILITY; ERYTHEMA; FEMALE; FOLLOW UP; HEMATOMA; HERPES ZOSTER; HOSPITALIZATION; HUMAN; IMMUNOCOMPROMISED PATIENT; INJECTION SITE REACTION; INOCULATION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PAIN; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RASH; SINGLE DRUG DOSE; SWELLING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; IMMUNOCOMPETENCE; MIDDLE AGED; MULTICENTER STUDY; NOTE; POSTHERPETIC NEURALGIA; RISK FACTOR;

AGED; AGED, 80 AND OVER; DOUBLE-BLIND METHOD; HERPES ZOSTER; HERPES ZOSTER VACCINE; HUMANS; IMMUNOCOMPETENCE; MIDDLE AGED; NEURALGIA, POSTHERPETIC; RISK FACTORS;

EID: 77952526262     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-152-9-201005040-00004     Document Type: Article

References (21)

1. Hope-Simpson RE. The nature of herpes zoster: a long-term study and a new hypothesis. Proc R Soc Med. 1965;58:9-20. [PMID: 14267505]
2. Chidiac C, Bruxelle J, Daures JP, Hoang-Xuan T, Morel P, Leplège A, et al. Characteristics of patients with herpes zoster on presentation to practitioners in France. Clin Infect Dis. 2001;33:62-9. [PMID: 11389496]
3. Schmader KE, Sloane R, Pieper C, Coplan PM, Nikas A, Saddier P, et al. The impact of acute herpes zoster pain and discomfort on functional status and quality of life in older adults. Clin J Pain. 2007;23:490-6. [PMID: 17575488]
4. van Seventer R, Sadosky A, Lucero M, Dukes E. A cross-sectional survey of health state impairment and treatment patterns in patients with postherpetic neuralgia. Age Ageing. 2006;35:132-7. [PMID: 16431855]
5. Levin MJ, Oxman MN, Zhang JH, Johnson GR, Stanley H, Hayward AR, et al; Veterans Affairs Cooperative Studies Program Shingles Prevention Study Investigators. Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine. J Infect Dis. 2008;197:825-35. [PMID:18419349]
6. Macaladad N, Marcano T, Guzman M, Moya J, Jurado F, Thompson M, et al. Safety and immunogenicity of a zoster vaccine in varicella-zoster virus seronegative and low-seropositive healthy adults. Vaccine. 2007;25:2139-44. [PMID: 17250932]
7. Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, et al; Shingles Prevention Study Group. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005;352:2271-84. [PMID: 15930418]
8. Oxman MN, Levin MJ; Shingles Prevention Study Group. Vaccination against herpes zoster and postherpetic neuralgia. J Infect Dis. 2008;197 Suppl 2:S228-S2236. [PMID: 18419402]
9. ICH Clinical Safety Data Management Guidance: Definitions and Standards for Expedited Reporting. Accessed at www.fda.gov/downloads/RegulatoryInformation/Guidances/UCM129518.pdf on 9 March 2010.
10. COSTART: Coding Symbols for Thesaurus of Adverse Reaction Terms. Fifth Edition. Rockville, MD: U.S. Food and Drug Administration. Report no. FDA/CDER-95/24. 1995.
11. Miettinen O, Nurminen M. Comparative analysis of two rates. Stat Med. 1985;4:213-26. [PMID: 4023479]
12. Kung HC, Hoyert DL, Xu J, Murphy SL. Deaths: Final Data for 2005. National Vital Statistics Reports. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System; 2008. Accessed at http://cdc.gov/nchs/data/nvsr/nvsr56/nvsr56_10.pdf on 9 March 2010.
13. Arvin AM. Cell-mediated immunity to varicella-zoster virus. J Infect Dis. 1992;166 Suppl 1:S35-S41. [PMID: 1320649]
14. Centers for Disease Control and Prevention. Update: vaccine side effects, adverse reactions, contraindications, and precautions. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 1996;45:1-35. [PMID: 8801442]
15. Murphy TV, Gargiullo PM, Massoudi MS, Nelson DB, Jumaan AO, Okoro CA, et al; Rotavirus Intussusception Investigation Team. Intussusception among infants given an oral rotavirus vaccine. N Engl J Med. 2001;344: 564-72. [PMID: 11207352]
16. Murphy BR, Morens DM, Simonsen L, Chanock RM, La Montagne JR, Kapikian AZ. Reappraisal of the association of intussusception with the licensed live rotavirus vaccine challenges initial conclusions. J Infect Dis. 2003;187: 1301-8. [PMID: 12696010]
17. Centers for Disease Control and Prevention (CDC). Smallpox vaccine adverse events among civilians-United States, March 4-10, 2003. MMWR Morb Mortal Wkly Rep. 2003;52:201-3. [PMID: 12653459]
18. Cassimatis DC, Atwood JE, Engler RM, Linz PE, Grabenstein JD, Vernalis MN. Smallpox vaccination and myopericarditis: a clinical review. J Am Coll Cardiol. 2004;43:1503-10. [PMID: 15120802]
19. Swerdlow DL, Roper MH, Morgan J, Schieber RA, Sperling LS, Sniadack MM, et al; Smallpox Vaccine Cardiac Adverse Events Working Group. Ischemic cardiac events during the Department of Health and Human Services Smallpox Vaccination Program, 2003. Clin Infect Dis. 2008;46 Suppl 3:S234-S241. [PMID: 18284364]
20. Sniadack MM, Neff LJ, Swerdlow DL, Schieber RA, McCauley MM, Mootrey GT. Follow-up of cardiovascular adverse events after smallpox vaccination among civilians in the United States, 2003. Clin Infect Dis. 2008;46 Suppl 3:S251-7. [PMID: 18284366]
21. Harpaz R, Ortega-Sanchez IR, Seward JF; Centers for Disease Control and Prevention. Prevention of Herpes Zoster: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Accessed at www.cdc.gov/mmwr/preview/mmwrhtml/rr5705a1.htm?s_cid=rr5705a1_e on 9 March 2010.